Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic

Detalles Bibliográficos
Autores principales: Díez, Javier, Bayes‐Genis, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721902/
https://www.ncbi.nlm.nih.gov/pubmed/29054841
http://dx.doi.org/10.1161/JAHA.117.007665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721902/
https://www.ncbi.nlm.nih.gov/pubmed/29054841
http://dx.doi.org/10.1161/JAHA.117.007665

Ejemplares similares